BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 8156901)

  • 1. Stimulation of glucagon-like peptide-1 secretion by muscarinic agonist in a murine intestinal endocrine cell line.
    Abello J; Ye F; Bosshard A; Bernard C; Cuber JC; Chayvialle JA
    Endocrinology; 1994 May; 134(5):2011-7. PubMed ID: 8156901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic receptors control glucagon-like peptide 1 secretion by human endocrine L cells.
    Anini Y; Brubaker PL
    Endocrinology; 2003 Jul; 144(7):3244-50. PubMed ID: 12810581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-regulated alteration of the affinity of pancreatic muscarinic cholinergic receptors.
    Doi R; Chowdhury P; Rayford PL
    J Biol Chem; 1993 Oct; 268(30):22436-43. PubMed ID: 7693670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.
    Anini Y; Hansotia T; Brubaker PL
    Endocrinology; 2002 Jun; 143(6):2420-6. PubMed ID: 12021207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line.
    Brubaker PL; Schloos J; Drucker DJ
    Endocrinology; 1998 Oct; 139(10):4108-14. PubMed ID: 9751489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological coupling and functional role for the muscarinic receptor subtypes in isolated cells from the circular smooth muscle of the rabbit cecum.
    Cuq P; Magous R; Bali JP
    J Pharmacol Exp Ther; 1994 Oct; 271(1):149-55. PubMed ID: 7965708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
    Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
    J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic responses of gastric parietal cells.
    Wilkes JM; Kajimura M; Scott DR; Hersey SJ; Sachs G
    J Membr Biol; 1991 Jun; 122(2):97-110. PubMed ID: 1895339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of muscarinic acetylcholine receptors on the rat pancreatic gastrin-producing cell line B6 RIN.
    Abello J; Roche C; Cuber JC; Bernard C; Philippe J; Chayvialle JA
    FEBS Lett; 1990 Sep; 270(1-2):37-40. PubMed ID: 2226784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptors in canine colonic circular smooth muscle. II. Signal transduction pathways.
    Zhang LB; Buxton IL
    Mol Pharmacol; 1991 Dec; 40(6):952-9. PubMed ID: 1661840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A human cellular model for studying the regulation of glucagon-like peptide-1 secretion.
    Reimer RA; Darimont C; Gremlich S; Nicolas-Métral V; Rüegg UT; Macé K
    Endocrinology; 2001 Oct; 142(10):4522-8. PubMed ID: 11564718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition.
    Baumgold J; White T
    Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    Mei L; Lai J; Roeske WR; Fraser CM; Venter JC; Yamamura HI
    J Pharmacol Exp Ther; 1989 Feb; 248(2):661-70. PubMed ID: 2537406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose.
    Damholt AB; Buchan AM; Kofod H
    Endocrinology; 1998 Apr; 139(4):2085-91. PubMed ID: 9528997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtype of muscarinic receptor coupled to the attenuation of hormone-stimulated cAMP accumulation in NG108-15 neuroblastoma x glioma hybrid cells.
    Stephan CC; Sastry BV
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):601-12. PubMed ID: 1282846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential coupling of m1, m2 and m3 muscarinic receptor subtypes to inositol 1,4,5-trisphosphate and adenosine 3',5'-cyclic monophosphate accumulation in Chinese hamster ovary cells.
    Burford NT; Tobin AB; Nahorski SR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):134-42. PubMed ID: 7616390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist-induced down-regulation and antagonist-induced up-regulation of m2- and m3-muscarinic acetylcholine receptor mRNA and protein in cultured cerebellar granule cells.
    Fukamauchi F; Saunders PA; Hough C; Chuang DM
    Mol Pharmacol; 1993 Nov; 44(5):940-9. PubMed ID: 8246917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.
    Katsuma S; Hirasawa A; Tsujimoto G
    Biochem Biophys Res Commun; 2005 Apr; 329(1):386-90. PubMed ID: 15721318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3-receptor activation inhibits cholinergic stimulation of acid secretion in isolated rabbit fundic glands.
    Bado A; Laigneau JP; Moizo L; Cherifi Y; Lewin MJ
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1099-103. PubMed ID: 8531069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.